Contents
Current Cancer Drug Targets, Volume 16 - Number 2
Editorial
Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response
, 16(2): 101 - 109Takayo Fukuda, Tomoko Tsuruga, Takako Kuroda, Hiroyuki Nishikawa and Tomohiko Ohta
DOI: 10.2174/1568009615666151030102427
Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer
, 16(2): 110 - 118Yasumichi Inoue, Yuka Itoh, Koichi Sato, Fumihiro Kawasaki, Chihiro Sumita, Takahito Tanaka, Daisuke Morishita and Hidetoshi Hayashi
DOI: 10.2174/1568009616666151112122126
The SCF-type E3 Ubiquitin Ligases as Cancer Targets
, 16(2): 119 - 129Kyoko Kitagawa and Masatoshi Kitagawa
DOI: 10.2174/1568009616666151112122231
E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers
, 16(2): 130 - 135Kazuma Masumoto and Masatoshi Kitagawa
DOI: 10.2174/1568009616666151112122336
Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy
, 16(2): 136 - 146Nobumichi Ohoka, Norihito Shibata, Takayuki Hattori and Mikihiko Naito
DOI: 10.2174/1568009616666151112122502
Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development
, 16(2): 147 - 156Satoshi Sakai, Chiharu Miyajima, Chiharu Uchida, Yuka Itoh, Hidetoshi Hayashi and Yasumichi Inoue
DOI: 10.2174/1568009616666151112122645
RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer
, 16(2): 157 - 174Chiharu Uchida and Masatoshi Kitagawa
DOI: 10.2174/1568009616666151112122801
Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment
, 16(2): 175 - 185Erika Giordani, Federica Zoratto, Martina Strudel, Anselmo Papa, Luigi Rossi, Marina Minozzi, Davide Caruso, Eleonora Zaccarelli, Monica Verrico and Silverio Tomao
DOI: 10.2174/1568009615666150817120712
Webmaster Contact: info@benthamscience.net